Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Voyager Therapeutics, Inc. (VYGR) had Operating Cash Flow per Share of $-0.65 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$6.47M |
|
$-31.02M |
|
-- |
|
$6.47M |
|
$41.17M |
|
$-34.69M |
|
$3.71M |
|
$-30.98M |
|
$-30.98M |
|
$-31.02M |
|
$-31.02M |
|
$-31.02M |
|
$-31.02M |
|
$-34.69M |
|
$-34.68M |
|
58.35M |
|
58.35M |
|
$-0.53 |
|
$-0.53 |
|
| Balance Sheet Financials | |
$245.21M |
|
$13.93M |
|
$108.03M |
|
$353.24M |
|
$40.21M |
|
-- |
|
$40.33M |
|
$80.54M |
|
$272.70M |
|
$272.70M |
|
$272.70M |
|
55.21M |
|
| Cash Flow Statement Financials | |
$-37.90M |
|
$41.20M |
|
$0.08M |
|
$74.24M |
|
$77.63M |
|
$3.39M |
|
$3.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.10 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-535.96% |
|
-535.96% |
|
-- |
|
-478.67% |
|
-479.24% |
|
$-38.55M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
3.07 |
|
29.34 |
|
-11.38% |
|
-11.38% |
|
-8.78% |
|
-11.38% |
|
$4.94 |
|
$-0.66 |
|
|
Operating Cash Flow per Share |
$-0.65 |